Chronic Hepatitis C-Related Cirrhosis Hospitalization Cost Analysis in Bulgaria

Chronic Hepatitis C-Related Cirrhosis Hospitalization Cost Analysis in Bulgaria

ObjectiveHCV infection is a leading cause of chronic liver disease with long-term complications—extensive fibrosis, cirrhosis, and hepatocellular carcinoma. The objective of this study is to perform cost analysis of therapy of patients with chronic HCV-related cirrhosis hospitalized in the Universit...

Full description

Bibliographic Details
Main Authors:	Maria Dimitrova, Kaloyan Pavlov, Konstantin Mitov, Jordan Genov, Guenka Ivanova Petrova
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-08-01
Series:	Frontiers in Medicine
Subjects:	chronic HCV infection HCV-related cirrhosis hospitalizations cost analysis burden
Online Access:	http://journal.frontiersin.org/article/10.3389/fmed.2017.00125/full

Similar Items

RELATIVE FREQUENCY OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS INFECTIONS IN PATIENTS OF LIVER CIRRHOSIS IN CHILDREN
by: Syed Nizam Hussain Shah, et al.
Published: (2020-02-01)

Biochemical and virological response of patients with Hepatitis C virus-caused cirrhosis to treatment with interferon and ribavirin
by: Zaily Dorta, et al.
Published: (2011-12-01)

Genotypes of Hepatitis C Virus and Efficacy of Direct-Acting Antiviral Drugs among Chronic Hepatitis C Patients in a Tertiary Care Hospital
by: Nahed Mohammed Hawsawi, et al.
Published: (2023-01-01)

Cost per care of the first year of direct antiviral agents in the Liguria Region: a multicenter analysis
by: Cenderello G, et al.
Published: (2017-05-01)

Predictors of seropositivity for human herpesvirus type 8 in patients with mild cirrhosis<subtitle>HHV-8 and mild cirrhosis</subtitle>
by: Kuo-Chih Tseng, et al.
Published: (2017-01-01)

Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district
by: Polilli E, et al.
Published: (2016-09-01)

Prognostic and diagnostic anthropometric biomarkers of sarcopenia in a cohort of Egyptian patients with hepatitis C-induced liver cirrhosis
by: Amany Nabil Abbasy, et al.
Published: (2023-06-01)

Egy-score as a noninvasive score for the assessment of hepatic fibrosis in chronic hepatitis C: A preliminary approach
by: Mohamed Alboraie, et al.
Published: (2014-01-01)

NON-INVASIVE TOOLS TO ASSESS THE RISK OF VARICES-NEEDING-TREATMENT IN CIRRHOSIS SECONDARY TO HCV
by: Laima Alam, et al.
Published: (2021-02-01)

Splenectomy in cirrhosis with hypersplenism: improvement in cytopenias, child's status and institution of specific treatment for hepatitis C with success
by: Saurabh Kedia, et al.
Published: (2012-11-01)

New therapies on the horizon for hepatitis C
by: Silvia C Sookoian, MD
Published: (2003-10-01)

The peritoneal macrophage inflammatory profile in cirrhosis depends on the alcoholic or hepatitis C viral etiology and is related to ERK phosphorylation
by: Tapia-Abellán Ana, et al.
Published: (2012-08-01)

Hepatitis C Virus Infection, A Risk Factor for Gallstone Disease: A Cross Sectional Survey
by: Samia Kausar , Fazilla Farid , Shamaila Burney , Kiran Fatima , Muhammad Farooq , Amina Shahzad
Published: (2021-12-01)

Hepatitis C virus quantification in serum and saliva of HCV-infected patients
by: Gisele Barreto Lopes Menezes, et al.
Published: (2012-08-01)

Factors Associated with Hepatitis C Infection among Chronic HCV Egyptian Patients.
by: Ekram W Abd El-Wahab, et al.
Published: (2014-11-01)

Clinical and epidemiological features of chronic hepatitis C in the north-western region of Ukraine
by: T. I. Bevz
Published: (2020-02-01)

The role of antiviral therapy in the management of patients with liver cirrhosis associated with chronic HBV and HCV infection
by: D. V. Garbuzenko
Published: (2021-11-01)

Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis
by: Steven Flamm, et al.
Published: (2023-09-01)

Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis
by: Antonio Riccardo Buonomo, et al.
Published: (2017-10-01)

Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial
by: Kiminori Kimura, et al.
Published: (2017-09-01)

Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?
by: Francesco Paolo Russo, et al.
Published: (2022-01-01)

Trends in the Acute Hepatitis B and Acute Hepatitis C in Bulgaria
by: Baymakova Magdalena P., et al.
Published: (2019-06-01)

Etiology of end-stage liver cirrhosis impacts hepatic natural killer cell heterogenicity
by: Ana C. Maretti-Mira, et al.
Published: (2023-03-01)

Study of some potential biomarkers in Egyptian hepatitis C virus patients in relation to liver disease progression and HCC
by: Kholoud Baraka, et al.
Published: (2023-10-01)

Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis
by: Nelson Cheinquer, et al.

Safety and Efficacy of Direct Antiviral Agents for Hepatitis C in Patients with Malignancies Other Than Liver Cancer: A Case Series
by: Fabian Patauner, et al.
Published: (2022-07-01)

Long non-coding RNA HOTAIR and HOTTIP as potential biomarkers for hepatitis C virus genotype 4-induced hepatocellular carcinoma
by: Fawzy Roshdy, et al.
Published: (2020-02-01)

Interleukin-18 polymorphism as a diagnostic tumor marker for hepatocellular carcinoma in patients with hepatitis C-related cirrhosis
by: Ayman Abdelghaffar Eldesoky, et al.
Published: (2020-11-01)

Liver cirrhosis: dispensary observation, the effectiveness of antiviral therapy
by: Y.H. Yupatau, et al.
Published: (2022-08-01)

Investigation of Genotype Distribution in Hepatitis C Patients in Giresun Province
by: Serpil GENÇ, et al.
Published: (2020-12-01)

Universal Index for Cirrhosis (UIC index): The development and validation of a novel index to predict advanced liver disease
by: Ahmed Z, et al.
Published: (2018-10-01)

The distribution of hepatitis C virus genotypes in patients with hepatocellular carcinoma
by: Ayfer Bakır, et al.
Published: (2019-10-01)

Detection and distribution of genotypes of Hepatitis C in a tertiary care hospital
by: Upasana Bhumbla, et al.
Published: (2020-01-01)

Prevalence and Genotypic Distribution of Hepatitis C Virus in Peshawar KPK, Pakistan
by: Tanweer Kumar, et al.
Published: (2017-01-01)

Genomic Relevance of <i>FGFR2</i> on the Prognosis of HCV-Induced Hepatocellular Carcinoma Patients
by: Walizeb Khan, et al.
Published: (2022-05-01)

Treatment of Chronic HCV Infection in Special Populations
Published: (2006-04-01)

Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulation
by: Cenderello G, et al.
Published: (2015-12-01)

Change in hepatitis C virus positivity among needle-stick injury source patients: a 10-year experience in a Japanese tertiary hospital
by: Kazuya Okushin, et al.
Published: (2021-04-01)

Clinical case of difficult differential diagnosis between liver cirrhosis and hepatocellular carcinoma associated with HCV infection in a patient with prolonged alcohol exposure
by: Baramzina S.V.
Published: (2019-12-01)

The Distribution of Hepatitis C Virus (HCV) Genotypes in 59 HCV Infected Patients: A Multicenter Study
by: Emine SÖNMEZ, et al.
Published: (1996-06-01)